- Home
- BMRN vs CLS Comparison
BMRN vs CLS Comparison
Compare BMRN & CLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- CLS
- Stock Information
- Founded
- BMRN 1996
- CLS 1994
- Country
- BMRN United States
- CLS Canada
- Employees
- BMRN N/A
- CLS N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- CLS Electrical Products
- Sector
- BMRN Health Care
- CLS Technology
- Exchange
- BMRN Nasdaq
- CLS Nasdaq
- Market Cap
- BMRN 12.1B
- CLS 9.7B
- IPO Year
- BMRN 1999
- CLS 1998
- Fundamental
- Price
- BMRN $54.97
- CLS $155.59
- Analyst Decision
- BMRN Buy
- CLS Strong Buy
- Analyst Count
- BMRN 22
- CLS 9
- Target Price
- BMRN $93.43
- CLS $117.00
- AVG Volume (30 Days)
- BMRN 2.2M
- CLS 3.3M
- Earning Date
- BMRN 08-04-2025
- CLS 07-23-2025
- Dividend Yield
- BMRN N/A
- CLS N/A
- EPS Growth
- BMRN 152.82
- CLS 37.60
- EPS
- BMRN 2.71
- CLS 3.58
- Revenue
- BMRN $2,950,227,000.00
- CLS $10,085,700,000.00
- Revenue This Year
- BMRN $12.23
- CLS $14.34
- Revenue Next Year
- BMRN $9.99
- CLS $16.83
- P/E Ratio
- BMRN $20.28
- CLS $43.60
- Revenue Growth
- BMRN 19.36
- CLS 21.05
- 52 Week Low
- BMRN $52.93
- CLS $40.25
- 52 Week High
- BMRN $94.85
- CLS $157.28
- Technical
- Relative Strength Index (RSI)
- BMRN 40.74
- CLS 80.66
- Support Level
- BMRN $53.76
- CLS $130.68
- Resistance Level
- BMRN $56.25
- CLS $139.89
- Average True Range (ATR)
- BMRN 1.26
- CLS 6.03
- MACD
- BMRN 0.06
- CLS 1.58
- Stochastic Oscillator
- BMRN 28.09
- CLS 92.17
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About CLS Celestica Inc.
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.